MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1272/jnms.jnms.2026_93-209

Медицинская библиотека · Journal of Nippon Medical School = Nippon Ika Daigaku zasshi · 2026

Sleep-Related Eating Disorder among Japanese Psychiatric Outpatients Receiving Ultra-Short-Acting Benzodiazepine Receptor Agonists: A Cross-Sectional Pilot Study.

Shimoda Kengo, Saito Haruki, Tateno Amane, Sakayori Takeshi, Nogami Tsuyoshi

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Sleep-related eating disorder (SRED) is a parasomnia characterized by involuntary nocturnal eating with amnesia, which can result in serious injuries, weight gain, and metabolic complications. Reports implicate the use of ultra-short-acting benzodiazepine receptor agonists (USBZRAs)-especially zolpidem-in SRED, but the magnitude of this risk in psychiatric patients remains unclear.

METHODS

We performed a cross-sectional observational survey at two Japanese hospitals of 157 psychiatric outpatients receiving one of four USBZRAs (triazolam, zopiclone, zolpidem, or eszopiclone) for ≥7 days. High-dose USBZRA therapy was defined as the maximum recommended dose per package insert. SRED was assessed using an International Classification of Sleep Disorders-based checklist. A Firth bias-reduced logistic regression model with four prespecified clinically relevant variables was employed due to the limited number of events.

RESULTS

Fourteen patients met SRED criteria (8.9%; 95% CI, 4.9-14.4). Zolpidem use (adjusted odds ratio [aOR] 5.98; 95% CI, 1.57-33.58) and high-dose USBZRA therapy (aOR 4.87; 95% CI, 1.56-17.51) were independently associated with SRED. Age (aOR 0.98; 95% CI, 0.94-1.02) and female sex (aOR 0.75; 95% CI, 0.22-2.87) were not significant.

CONCLUSIONS

The observed prevalence aligns with earlier reports, confirming that nearly one in eleven psychiatric outpatients receiving USBZRAs experiences SRED. Our study extends prior work by showing that SRED risk is highest at the maximum recommended dose, and especially with zolpidem. The wide confidence intervals reflect the small number of events and should be interpreted as hypothesis generating rather than definitive. These findings support limiting USBZRA dosage, favoring lower-risk hypnotics, and actively screening for nocturnal eating. This pilot study warrants validation in larger cohorts.

Для цитирования: Shimoda Kengo, Saito Haruki, Tateno Amane, Sakayori Takeshi, Nogami Tsuyoshi. Sleep-Related Eating Disorder among Japanese Psychiatric Outpatients Receiving Ultra-Short-Acting Benzodiazepine Receptor Agonists: A Cross-Sectional Pilot Study.. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 2026. DOI: 10.1272/jnms.jnms.2026_93-209.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.